Clinical utility of denosumab for treatment of bone loss in men and women
Robert A Adler, Ranjodh S GillEndocrinology and Metabolism, McGuire Veterans Affairs Medical Center, Richmond, VA, USAAbstract: While most older patients with osteoporosis are treated with antiresorptive bisphosphonates such as alendronate, risedronate, ibandronate, and zoledronic acid, such drugs h...
Enregistré dans:
Auteurs principaux: | Adler R, Gill RS |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/75b6a79ef62d4aab9660aac39a7c9067 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Frequency of osteoporosis in patients with peptic ulcer disease
par: Amber Amin, et autres
Publié: (2021) -
Osteonecrosis de los maxilares asociada a medicamentos: revisión de la literatura y propuesta para la prevención y manejo
par: Foncea,Camila, et autres
Publié: (2020) -
Osteoporosis in men: epidemiology and treatment with denosumab
par: Sidlauskas KM, et autres
Publié: (2014) -
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
par: Pan WL, et autres
Publié: (2017) -
Treatment of primary osteoporosis in men
par: Giusti A, et autres
Publié: (2014)